At Cancilico, we use artificial intelligence and computer vision to shape the image-based diagnostics of tomorrow. Building upon our multidisciplinary expertise in computer science and clinical medicine, we are dedicated to transforming the way diseases such as hematological cancers are diagnosed and studied. Our mission is to harness the power of AI to substantially improve diagnostics in clinical routine and as part of clinical trials, making it more accurate, efficient, and accessible. Our suite of advanced, user-friendly AI technology can identify relevant mutations and target structures for the development of digital biomarkers. Additionally, we offer our AI capabilities to academic institutions, medical research centers and industry partners and help them drive their research and development forward.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Blasewitzer Straße 9, Dresden,sachsen 01307,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cancilico.com/
- Keywords
- Artificial Intelligence, Computer Vision, Machine Learning, Cancer, Diagnostics, Treatment, Digitization, Consulting, Project Development, Hematology, Digital Biomarkers.
- HQ
- Dresden, Sachsen
Cancilico Questions
Cancilico's website is https://cancilico.com/
Cancilico's LinkedIn profile is https://de.linkedin.com/company/cancilico
Cancilico has
8 employees.
View email and phone details for 8
employees at Cancilico.
Cancilico's industry is
Biotechnology Research
Cancilico's top competitors are
Connected Consumables,
Synagen Ai,
Ecovery Gmbh,
Synlab Holding Deutschland Gmbh,
Ppt Pharma Process Technology Group,
Saxocell Cluster,
Siemens Energy,
Imk Health Intelligence,
Intu Diagnostics,
Innomotics.
Cancilico's categories are Biotechnology Research
Cancilico's founding year is 2023
